相似文献
1
Author Correction: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity.
Nat Neurosci. 2022 Nov;25(11):1582. doi: 10.1038/s41593-022-01206-2.
2
Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.
Exp Cell Res. 2008 Jun 10;314(10):2076-89. doi: 10.1016/j.yexcr.2008.03.012. Epub 2008 Mar 28.
3
α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.
Mov Disord. 2020 Feb;35(2):268-278. doi: 10.1002/mds.27907. Epub 2019 Nov 23.
4
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase.
J Neurosci. 2016 Oct 12;36(41):10510-10521. doi: 10.1523/JNEUROSCI.1659-16.2016.
5
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2634-E2643. doi: 10.1073/pnas.1713849115. Epub 2018 Feb 27.
6
Author Correction: Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein.
Nat Neurosci. 2023 Dec;26(12):2250. doi: 10.1038/s41593-023-01474-6.
7
α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca homeostasis and mitochondrial ATP production.
Acta Neuropathol. 2017 Jul;134(1):129-149. doi: 10.1007/s00401-017-1704-z. Epub 2017 Mar 23.
8
α-Synuclein fibrillation products trigger the release of hexokinase I from mitochondria: Protection by curcumin, and possible role in pathogenesis of Parkinson's disease.
Biochim Biophys Acta Biomembr. 2020 Jun 1;1862(6):183251. doi: 10.1016/j.bbamem.2020.183251. Epub 2020 Feb 28.
9
Alpha-Synuclein Aggregates Associated with Mitochondria in Tunnelling Nanotubes.
Neurotox Res. 2021 Apr;39(2):429-443. doi: 10.1007/s12640-020-00285-y. Epub 2020 Sep 14.
10
Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?
Genes (Basel). 2017 Dec 8;8(12):377. doi: 10.3390/genes8120377.
引用本文的文献
1
Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel.
Int J Mol Sci. 2025 May 8;26(10):4503. doi: 10.3390/ijms26104503.
2
Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies.
Biomedicines. 2025 Jan 31;13(2):327. doi: 10.3390/biomedicines13020327.
3
Molecular Determinants of Protein Pathogenicity at the Single-Aggregate Level.
Adv Sci (Weinh). 2025 Mar;12(9):e2410229. doi: 10.1002/advs.202410229. Epub 2025 Jan 13.
4
HSPB6: A lipid-dependent molecular chaperone inhibits α-synuclein aggregation.
iScience. 2024 Aug 3;27(9):110657. doi: 10.1016/j.isci.2024.110657. eCollection 2024 Sep 20.
5
Mitochondrial complex I subunit mutations affect disease progression.
Heliyon. 2024 Mar 28;10(7):e28808. doi: 10.1016/j.heliyon.2024.e28808. eCollection 2024 Apr 15.
Zotero 插件